Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2441087
Max Phase: Preclinical
Molecular Formula: C25H23ClFN5O5
Molecular Weight: 527.94
Molecule Type: Small molecule
Associated Items:
ID: ALA2441087
Max Phase: Preclinical
Molecular Formula: C25H23ClFN5O5
Molecular Weight: 527.94
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cccc([C@H]2O[C@H](CCn3cc(C(=O)O)cn3)c3nnc(CF)n3-c3ccc(Cl)cc32)c1OC
Standard InChI: InChI=1S/C25H23ClFN5O5/c1-35-19-5-3-4-16(23(19)36-2)22-17-10-15(26)6-7-18(17)32-21(11-27)29-30-24(32)20(37-22)8-9-31-13-14(12-28-31)25(33)34/h3-7,10,12-13,20,22H,8-9,11H2,1-2H3,(H,33,34)/t20-,22-/m1/s1
Standard InChI Key: VYODEMHPMQHSGG-IFMALSPDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 527.94 | Molecular Weight (Monoisotopic): 527.1372 | AlogP: 4.55 | #Rotatable Bonds: 8 |
Polar Surface Area: 113.52 | Molecular Species: ACID | HBA: 9 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.43 | CX Basic pKa: 1.03 | CX LogP: 2.91 | CX LogD: -0.49 |
Aromatic Rings: 4 | Heavy Atoms: 37 | QED Weighted: 0.35 | Np Likeness Score: -0.96 |
1. Ichikawa M, Ohtsuka M, Ohki H, Ota M, Haginoya N, Itoh M, Shibata Y, Ishigai Y, Terayama K, Kanda A, Sugita K.. (2013) Discovery of DF-461, a Potent Squalene Synthase Inhibitor., 4 (10): [PMID:24900587] [10.1021/ml400151c] |
Source(1):